Oral agents have changed the CLL treatment landscape. But how does their cost affect patients? Here's a review of our #ASH24 abstract on the relationship between financial toxicity, medication adherence, and health-related QOL in CLL pts on 1L oral therapy #lymsm 🧵/1
@majorajay.bsky.social

First pie baked at altitude… cherry pie a la Sally’s Baking Addiction using the Betty Crocker pie crust recipe! Presentation could use work but overall a success

Lee, et al. from Stanford present results in 24 octogenarians treated with CD19 CAR-T cells.

Overall, higher ICANS rate and much longer LOS (30d vs. 16d) v. age 65-79. Long LOS driven by toxicity.

Similar overall PFS, outcomes suggest safety/efficacy in selected patients. #ASH24 #immunotherapy

Staggering statistics at #ASH24 #TreatingFairly

Patients with cancer who go bankrupt are nearly 80% more likely to die regardless of disease status.

Our system quite literally kills people.

Can't congratulate Dr. Allen enough on her #ASH24 abstract; keep your eyes peeled for a manuscript in 2025! And the whole @cuanschutz.bsky.social internal med gang showed up, too! #ASHKudos #lymsm cc @jessicaallenmd.bsky.social @vpizzuti.bsky.social

Preview of my mentee Dr. Allen's (@jessicaallenmd.bsky.social) study at tonight's #ASH24 poster session. Patient-reported financial toxicity and suboptimal adherence is already substantial in the first few months of initiation of first-line oral oncolytics for CLL, and affects HRQOL. #lymsm #leusm

For #ASH24 goers, please check out our #lymsm PRO abstracts:
- Saturday PM: @jessicaallenmd.bsky.social presenting FT & adherence in 1L CLL oral oncolytics
- Monday PM: Dr. Pizzuti presenting heatmap modeling of longitudinal PROs from our BISON-PRO registry (bison-pro.org)

CU soon in San Diego for a fabulous weekend!! #ASH24

Kicking off for the University of Colorado team today is
Dr. Manali Kamdar.

For more CU team weekend activities: bit.ly/CUHematology...

#HemeOnc #Hematology #BloodSky

So excited to attend my first ASH! #ASH24
@ash-hematology.bsky.social